Global Travel Media » Blog Archive » The U.S.’s COVID-19 Testing: The Dishonesty Continues

Home » Coronavirus (Covid-19) » Currently Reading:

The U.S.’s COVID-19 Testing: The Dishonesty Continues

July 10, 2020 Coronavirus (Covid-19) No Comments Email Email


Over and over, we’ve heard federal and state officials – especially elected ones – assert that the recent explosion in reported COVID-19 cases is due to more and better testing in the U.S. That is a dishonest assertion, and in the face of a pandemic, a recklessly dangerous one.

Think of COVID-19 testing as falling into two categories:  Necessary Testing and Strategic Testing.  Necessary Testing happens because a person gets sick; there must be at least one test performed to confirm the COVID-19 diagnosis and at least two more to confirm the patient has recovered, plus a few of tests of the patient’s housemates and other obvious candidates for testing.  The remainder are Strategic Tests – these are the tests we perform as a result of contact tracing; regular tests of employees in sensitive industries like health care, food services, and public safety; and regular tests of other people, especially in their workplaces.

Or, in the metaphor of the above epigraph, Necessary Testing is for getting rid of the alligators, and Strategic Testing is for draining the swamp. 

Strategic Testing is the true measure of a nation’s effort to control the spread of the pandemic.  Let’s assume that each reported case generates six Necessary Tests, so the number of Strategic Tests equals the total number of tests reported, minus six times the number of Total Cases reported.  The following graph shows the progress of Strategic Testing in 41 countries over the last ten weeks.  These countries include most of Europe, plus relatively affluent countries in the rest of the world – it would be unreasonable to include poor and developing nations in this comparison:

Strategic testing has improved significantly in the U.S., from being virtually nonexistent ten weeks ago.  But most of the other countries shown have made similar increases.  Of the 41 countries shown, as of July 2 the U.S. ranked 23rd in Total Strategic Tests per 1MM population.

At this point, most of the world’s affluent countries have a huge advantage over the U.S. when it comes to testing:  Their New Cases have dropped to such low levels that virtually all of their testing capacity can be devoted to Strategic Testing rather than Necessary Testing.  The daily rate of New Cases in the U.S. is ten to twenty times the rate in most of those other countries, so all we can do is cope with the alligators, while Europe, Canada, Australia, New Zealand, Japan, Taiwan, and South Korea can focus on draining the swamp.

The assertion that the U.S. leads the world in COVID-19 testing is flatly dishonest, especially when the real cause of the increase in reported cases is a raging pandemic.  To drag another metaphor into the conversation:  That assertion is nothing more than fiddling while the nation burns.



Comment on this Article:







Time limit is exhausted. Please reload CAPTCHA.

Platinium Partnership

ADVERTISEMENTS

Elite Partnership Sponsors

ADVERTISEMENTS

Premier Partnership Sponsors

ADVERTISEMENTS

Official Media Event Partner

ADVERTISEMENTS

Global travel media endorses the following travel Publication

ADVERTISEMENTS

GLOBAL TRAVEL MEDIA VIDEOS

ADVERTISEMENTS



sitemap